Mirum Pharmaceuticals Inc (MIRM) — Cash Flow Quality Index

Latest as of September 2025: 13.66x

Mirum Pharmaceuticals Inc (MIRM) has a Cash Flow Quality Index of 13.66x as of September 2025. Operating cash flow of $39.68 Million exceeds net income of $2.90 Million, indicating high earnings quality where cash backs reported profits. Explore Mirum Pharmaceuticals Inc (MIRM) investment intensity to see how much of total assets are deployed in long-term investments.

Cash Flow Quality Index

13.66x

Operating CF / Net Income

Operating Cash Flow

$39.68 Million

USD

Net Income

$2.90 Million

USD

Data as of

Sep 2025

Most recent filing

Annual Cash Flow Quality Index for Mirum Pharmaceuticals Inc (None–None)

Year-by-year earnings quality comparison for Mirum Pharmaceuticals Inc. For live market cap and the full company financial profile, see Mirum Pharmaceuticals Inc market capitalisation.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.